Activation of beta-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis
Liu, LA; Zhu, XD; Wang, WQ; Shen, YA; Qin, Y; Ren, ZG; Sun, HC; Tang, ZY
刊名CLINICAL CANCER RESEARCH
2010
卷号16期号:10页码:2740-2750
通讯作者Tang, ZY (reprint author), Fudan Univ, Liver Canc Inst, 136 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.,zytang88@163.com
英文摘要Purpose: Aberrant activation of beta-catenin contributes to the malignant phenotype in hepatocellular carcinoma (HCC). Hypoxia is also known to promote HCC invasion and metastasis. However, the association between beta-catenin and the proinvasive role of hypoxia remains unclear. We investigated the role of beta-catenin in the proinvasive consequences of hypoxia in HCC. Experimental Design: We established in vitro and in vivo hypoxic models to investigate the expression of beta-catenin in hypoxic HCC cells and its role in hypoxia-induced aggressiveness. The clinical significance of beta-catenin and/or hypoxia-induced factor-1 alpha (HIF-1 alpha) was evaluated using HCC tissue microarrays. Results: Hypoxia induced beta-catenin overexpression and/or intracellular accumulation in four HCC cell lines through downregulating the endogenous degradation machinery, and promoted in vitro invasion and in vivo metastasis of MHCC97 and Hep3B cells. Besides morphologic changes, hypoxic MHCC97 and Hep3B cells exhibited molecular alterations consistent with epithelial-mesenchymal transition, characterized by the loss of epithelial cell markers (E-cadherin and plakoglobin) and upregulation of mesenchymal markers (vimentin and N-cadherin), as well as the increase of matrix metalloproteinase 2. However, silencing beta-catenin in these hypoxic cells reversed epithelial-mesenchymal transition and repressed metastatic potential. Positive expression of beta-catenin in HCC tissue microarray was associated with the expression of HIF-1 alpha (P = 0.034), and coexpression of beta-catenin and HIF-1 alpha in HCC was correlated with shorter overall survival and time to recurrence. Conclusion: beta-Catenin in HCC is activated by hypoxia and contributes to hypoxia-induced metastatic potential. Clin Cancer Res; 16(10); 2740-50. (C) 2010 AACR.
学科主题Oncology
类目[WOS]Oncology
关键词[WOS]EPITHELIAL-MESENCHYMAL TRANSITION ; TUMOR-GROWTH ; PATHWAYS ; PATHOGENESIS ; EXPRESSION ; SURVIVAL ; DISEASE ; CANCER ; CELLS ; MODEL
收录类别SCI
语种英语
WOS记录号WOS:000278597600006
内容类型期刊论文
版本出版稿
源URL[http://202.127.25.143/handle/331003/1061]  
专题上海生化细胞研究所_上海生科院生化细胞研究所
推荐引用方式
GB/T 7714
Liu, LA,Zhu, XD,Wang, WQ,et al. Activation of beta-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis[J]. CLINICAL CANCER RESEARCH,2010,16(10):2740-2750.
APA Liu, LA.,Zhu, XD.,Wang, WQ.,Shen, YA.,Qin, Y.,...&Tang, ZY.(2010).Activation of beta-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis.CLINICAL CANCER RESEARCH,16(10),2740-2750.
MLA Liu, LA,et al."Activation of beta-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis".CLINICAL CANCER RESEARCH 16.10(2010):2740-2750.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace